Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
Mon, 18.03.2024
Medios AG
Medios acquires Dutch market leader in pharmaceutical compounding services
Berlin, March 18, 2024 – Medios AG (“Medios”), the leading provider of Specialty Pharma Solutions in Germany, acquires Ceban Pharmaceuticals B.V. ("Ceban"), a fast-growing pharmaceutical compounding platform operating in the Netherlands, Belgium and Spain. With the combinat [ … ]
Mon, 18.03.2024
Delivery Hero SE
NOT FOR DISTRIBUTION, PUBLICATION OR FORWARDING, EITHER DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS PUBLICATION.
Public disclosur [ … ]
Mon, 18.03.2024
CEWE Stiftung & Co. KGaA
Ad Hoc Release
CEWE plans fifteenth dividend increase in a row
Oldenburg, 18 March 2024. The Board of Management of CEWE Stiftung & Co. KGaA (SDAX, ISIN: DE0005403901) resolved in its meeting of today to propose to the Supervisory Board, on the basis of the preliminary unaudited figures for the 2023 financial year, to raise the dividend [ … ]
Mon, 18.03.2024
KATEK SE
KATEK intends to enter into a delisting agreement with Kontron Acquisition GmbH
Munich, March 18, 2024 - The Management Board of KATEK SE has decided today to enter into a delisting agreement with Kontron Acquisition GmbH. Kontron Acquisition GmbH, a wholly owned subsidiary of the listed Kontron AG, Linz (Austria), announced the acquisition of con [ … ]
Mon, 18.03.2024
aap Implantate AG
Publication of inside information pursuant to Article 17 of Regulation (EU) No 596/2014
The Management Board of aap Implantate AG ("Company") resolved today, with the approval of the Supervisory Board, to increase the Company's share capital against cash contributions by issuing new no-par value bearer shares with a pro rata amount of the share c [ … ]
Mon, 18.03.2024
ELARIS AG
Public disclosure of inside information according to Article 17 of Regulation (EU) No 596/2014
ELARIS AG resolves to carry out a capital increase for cash from authorised capital with the exclusion of subscription rights in April 2024
Issue price per new share expected to be EUR 41.50
Expected total proceeds of around EUR 3.5 million to b [ … ]
Mon, 18.03.2024
Julius Baer Group Ltd.
Ad hoc announcement pursuant to Art. 53 LR
Zurich, 18 March 2024 – Julius Baer Group today published its Annual Report 2023 (including the Remuneration Report), the Sustainability Report 2023 and Business Review 2023 as well as the Annual Report 2023 (Financial Statement IFRS) of Bank Julius Baer & Co. Ltd. The documents are available for downl [ … ]
Mon, 18.03.2024
Meyer Burger Technology AG
Ad hoc announcement pursuant to Art. 53 LR
Thun, March 18, 2024
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL
Meyer Burger announces the terms of its rights issue of around CHF 200 million and amends i [ … ]
Mon, 18.03.2024
Comet Holding AG
Ad hoc announcement pursuant to Art. 53 LRComet will propose to the Annual General Meeting (AGM) on April 19, 2024, the election of Paul Boudre as successor to Heinz Kundert as Chairman of the Board of Directors. Heinz Kundert will stand for re-election as a member of the Board of Directors for another year to ensure a smooth transition. At the sam [ … ]
Fri, 15.03.2024
Alzchem Group AG
Trostberg, 15 March 2024 - Following a Europe-wide selection process, Alzchem Group AG has been awarded an investment grant of EUR 34.4 million by the EU Commission as part of the ASAP ("Act in Support of Ammunition Production") funding instrument.
Alzchem Group AG wants to use the funds over an investment period of two and a half years to increase [ … ]